JNJ-1802
Treatment-Resistant Depression
Phase 2Active
Key Facts
About Johnson & Johnson
Founded in 1886, Johnson & Johnson operates as a multinational healthcare corporation headquartered in New Brunswick, New Jersey. The company's pharmaceutical division, Janssen, is a global leader in oncology, immunology, and neuroscience with blockbuster drugs like Stelara, Darzalex, and Remicade. J&J combines deep scientific expertise with extensive global reach, serving patients in over 175 countries while maintaining one of the industry's strongest R&D pipelines.
View full company profileOther Treatment-Resistant Depression Drugs
| Drug | Company | Phase |
|---|---|---|
| DSP-6745 | Sumitomo Pharma | Phase 1 |
| ML-104 | MapLight Therapeutics | Preclinical |
| PSG-301 | PharmaSGP | Preclinical |